
Conference Coverage
9 days ago
Busting ADHD Myths at APSARDLatest Content

Shorts










Digital Edition
Podcasts
Continuing Medical Education
All News

Explore how futures thinking empowers mental health professionals to navigate climate change impacts, fostering resilience and agency in uncertain times.

Explore the gradual dangers of societal issues like climate change and mental health, and learn how early intervention can make a difference.


Therapeutic drug monitoring revolutionizes psychiatric care, enhancing treatment precision and patient outcomes through real-time data and personalized medicine strategies.

Explore the concept of interdependence in politics and psychiatry, emphasizing connection and cooperation to enhance mental health and societal well-being.

Government funding cuts to mental health and addiction programs create chaos, prompting swift restoration amid widespread concern from advocacy groups. Read the statement from the AFSP here.

In this CME article, explore the groundbreaking role of muscarinic cholinergic receptors in schizophrenia treatment, highlighting innovative therapies like KarXT for improved patient outcomes.

Artificial intelligence revolutionizes sports, enhancing performance and officiating, while raising concerns about the human element of competition.

Explore the multifaceted role of time in psychotherapy, from patient dynamics to treatment duration, and its impact on healing and growth.

LPCN 1154 shows promise as a rapid, at-home treatment for postpartum depression, with favorable safety results in ongoing phase 3 trials.

Exploring the vital link between nutrition and mental health, this article highlights dietary strategies to enhance psychiatric well-being and cognitive function.

Inpatient psychiatry faces an epidemic of violence, highlighting systemic neglect and the urgent need for reform to protect health care workers.

Explore the evolving landscape of psychiatry as it reflects on past events, current challenges, and future predictions for mental health.

BioXcel Therapeutics submits an sNDA to the FDA for Igalmi to treat agitation in bipolar disorder and schizophrenia at home.















































